Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

Also called NCT06721221

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Semmelweis University (from the registry)
Registry
  • NCT NCT06721221
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hungary (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06721221. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation
Acronym
SVtag
Condition
Atrial Fibrillation (AF)
Condition
Atrial Fibrillation Ablation
Condition
Pulmonary Vein Isolation
Intervention (Device)
Point-by-point PVI with the QDot Micro catheter in QMODE+ setting with the Svtag software
Lead sponsor
Semmelweis University (class: other)

Record details

Record id
cardio:ct-nct06721221
Content hash
0a4237eac7cfb0e55402cb8818d57b28f8e02723881fc6a9ddc1e633c7304e61